Qiang Zou
- Immunology top 2%
- Immune Cell Function and Interaction 20
- T-cell and B-cell Immunology 15
- Immunotherapy and Immune Responses 12
- interferon and immune responses 8
- Immune Response and Inflammation 8
- Cancer Research top 5%
- NF-κB Signaling Pathways 9
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways 7
- RNA modifications and cancer 6
- Oncology top 5%
- Pharmacology top 10%
- Journals
- The Journal of Experimental Medicine (6 papers)Nature Communications (4 papers)Journal of Clinical Investigation (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Qiang Zou
76 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Immunology 1.1k
- Cancer Research 552
- Molecular Biology 1.3k
- Oncology 489
- Pharmacology 74
Countries citing papers authored by Qiang Zou
This map shows the geographic impact of Qiang Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiang Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiang Zou more than expected).
Fields of papers citing papers by Qiang Zou
This network shows the impact of papers produced by Qiang Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiang Zou. The network helps show where Qiang Zou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qiang Zou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 19 | |
| 2 | 2024 | 10 | |
| 3 | Lactate modulates RNA splicing to promote CTLA-4 expression in tumor-infiltrating regulatory T cellsbreakdown → | 2024 | 64 |
| 4 | 2024 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 58 | |
| 7 | 2022 | 58 | |
| 8 | 2022 | 5 | |
| 9 | 2021 | 135 | |
| 10 | 2021 | 54 | |
| 11 | 2020 | 30 | |
| 12 | 2019 | 5 | |
| 13 | 2017 | 65 | |
| 14 | 2016 | 85 | |
| 15 | 2015 | 44 | |
| 16 | 2015 | 16 | |
| 17 | Arbitrage Strategy between Stock Future Markets Related to China:On the Stock Index Futures of CSI300,FTSE A50 and HSCEI | 2012 | 1 |
| 18 | 2012 | 4 | |
| 19 | 2012 | 9 | |
| 20 | 2010 | 129 |
About Qiang Zou
Qiang Zou is a scholar working on Immunology, Cancer Research and Physiology, having authored 78 papers that have together received 2.5k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (20 papers), T-cell and B-cell Immunology (15 papers), Immunotherapy and Immune Responses (12 papers), NF-κB Signaling Pathways (9 papers), interferon and immune responses (8 papers), Immune Response and Inflammation (8 papers), Ubiquitin and proteasome pathways (7 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Immunology (1.1k citations), Cancer Research (552 citations) and Molecular Biology (1.3k citations). Qiang Zou has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jin Jin, Xuhong Cheng, Hongbo Hu, Yichuan Xiao, Shao‐Cong Sun, Zhilin Hu, Xiaoping Xie, Xiaofei Zhou, Huabing Li and Haiyan S. Li. Their work appears in journals such as The Journal of Experimental Medicine, Nature Communications, Journal of Clinical Investigation, Science Advances and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.